All-trans retinoic acid (RA), the principal biologically active form of vitamin A, is essential for many developmental process as well as homeostasis in the adult. Many lines of evidence also suggest that RA, acting through the RA receptors (RARs), can also suppress growth of tumors of diverse origin. To assess directly the role of the RARs in a model of epidermal tumorigenesis, we investigated the incidence of tumor formation using keratinocytes lacking specific RAR types. Our data suggest that loss of RARc, but not RARa, predisposed keratinocytes to v-Ha-Rasinduced squamous cell carcinoma. We also found that ablation of RARc, but not RARa, abolished RA-induced cell cycle arrest and apoptosis in these keratinocytes. Reconstitution of receptor expression into RAR-null cells restored sensitivity to RA, and reversed the tumorigenic potential of receptor-deficient keratinocytes. These data strongly support a tumor suppressor effect for the RARs, in particular endogenous RARc, in murine keratinocytes.
Introduction
All-trans retinoic acid (RA), the major biologically active form of vitamin A, is an important regulator of vertebrate development, and is essential for maintenance of many adult tissues (Chambon 1996; Fisher and Voorhees 1996; Ross et al., 2000) . The biological functions of RA are mediated by two members of the nuclear receptor family, the retinoic acid receptors (RARa, RARb and RARg and their isoforms) and the retinoid X receptors (RXRa, RXRb and RXRg and their isoforms) (Chambon 1996; Altucci and Gronemeyer 2001; Wei 2003) .
RARs modulate gene expression by binding to cisacting response elements (RAREs) in the promoter/ enhancer region of target genes as heterodimers with RXRs (Kastner et al., 1995; Chambon, 1996; Wei, 2003) . In the absence of ligand, these heterodimers associate with transcriptional corepressor complexes, including histone deactyltransferases, resulting in chromatin condensation and suppression of gene transcription. Ligand-binding mediates conformational changes in the receptor, leading to disassociation of corepressors and recruitment of coactivators, which either have intrinsic histone acetyltransferase (HAT) activity or associate with HATs. HAT function leads to decondensation of chromatin, facilitating gene transcription (Xu et al., 1999; Wei, 2003) .
In addition to direct regulation of target genes, RARs, like several other nuclear receptors, can impact on gene expression by trans-repression of other transcription factors, such as activating protein 1 (AP-1) (Altucci and Gronemeyer, 2001; Mehta, 2003) . AP-1 activity has been closely linked to epidermal tumorigenesis in vivo and cellular transformation in vitro (Jochum et al., 2001) . While the basis for this effect is not fully understood, trans-repression of AP-1 has been suggested to be responsible for the growth inhibitory effects of RA in many cell types, including keratinocytes (Karin et al., 1997; Goyette et al., 2000) .
RA has long been known to influence epidermal development and differentiation (Fisher and Voorhees, 1996) . Among the retinoid receptors, normal cutaneous epidermis and cultured keratinocytes express RARa and RARg, as well as RXRa and RXRb, with RARg and RXRa being the predominant RAR and RXR types (Darwiche et al., 1995; Fisher and Voorhees, 1996) . Pharmacological concentrations of RA can inhibit the growth of transformed keratinocytes in culture, and this effect is mediated largely through RARg (Goyette et al., 2000) , suggesting a key role for this receptor in keratinocyte growth and differentiation. However, in contrast to observations using exogenous retinoids, murine knockout models suggest that the RARs have only a minor effect on development and homeostasis of the epidermis under normal conditions Chapellier et al., 2002) . These findings, however, do not preclude a role for retinoid signaling in pharmacological settings or under pathological conditions.
A role for retinoid signaling in epithelial tumorigenesis has been suggested by numerous observations. Treatment with certain tumor promoters, such as TPA (12-O-tetradecanolphorbol-13-acetate) or merazein, or exposure to ultraviolet radiation, the major causative factor of nonmelanoma skin cancers (Marks, 1995) , leads to a decrease in the expression of both RARa and RARg in the epidermis (Kumar et al., 1994; Darwiche et al., 1995; Wang et al., 1999) . Expression of these receptors is also gradually lost with progression of skin tumors from a benign lesion to malignant squamous cell carcinoma (SCC) (Darwiche et al., 1995; Xu et al., 2001) . Similar relationships between extinction of RAR expression and tumorigenesis have been observed for a number of other carcinomas, including lung, breast and head and neck cancers (Altucci and Gronemeyer, 2001; Sun and Lotan, 2002) .
We previously found that RA inhibits the growth of transformed keratinocytes in culture primarily through RARg (Goyette et al., 2000) . In this study, we assessed the consequence of RAR ablation on v-Ha-Ras-induced keratinocyte tumorigenesis. We found that loss of RARg, but not RARa, predisposed keratinocytes to Rasinduced tumorigenesis. This effect correlated with the loss of RA-induced cell cycle arrest and apoptosis as well as inhibition of AP-1 activity. Taken together, our findings are consistent with a role for the RARs, and in particular RARg, as tumor suppressors in murine keratinocytes.
Results

RARg suppresses Ras-induced tumorigenesis
Previous studies revealed a correlation between the loss of RARa and RARg and development of papillomas and SCC in both mouse and man (Darwiche et al., 1995; Xu et al., 2001) . To further investigate this relationship, we assessed the effects of loss of these receptors on tumorigenesis. Owing to the perinatal lethality caused by disruption of RARa and/or RARg Lufkin et al., 1993) , we used immortalized keratinocyte cell lines lacking one or both of these receptor types as a model system and examined their predisposition to tumor formation in nude mice.
Neither the wild-type nor any of the RAR-null cells formed tumors following subcutaneous (sc) injection in nude mice (data not shown). However, following transduction with a v-Ha-ras retrovirus (Roop et al., 1986) , RARg À/À and RARag À/À cells, but not wild-type or RARa À/À cells, gave rise to tumors at a high incidence (Table 1) . Western blot analysis indicated that the predisposition of RARg À/À or RARag À/À cells to develop tumors was not due to variation in oncogene expression, as all lines exhibited similar levels of Ha-Ras following retroviral transduction irrespective of genotype. Moreover, all tumors were of polyclonal origin as assessed by Southern blot (data not shown).
Histologically, tumors derived from both RARg
and RARag À/À cultures exhibited characteristics consistent with SCC (data not shown). In agreement with this, Northern blot analysis showed a lack of expression of K10, indicative of malignant conversion (Nelson and Slaga, 1982) , and gain of expression of K8, a marker associated with the malignant epithelial phenotype (Larcher et al., 1992) . K13, a premalignant marker of skin tumor progression (Gimenez-Conti et al., 1990) , was not detected (data not shown).
These studies suggest that loss of RARg predisposed keratinocytes to Ras-induced tumorigenesis, and that RARg may function to suppress both tumor formation and the malignant conversion of the epidermal tumors. Interestingly, although RARa À/À cells were not predisposed to tumorigenesis in this model system, tumors derived from RARag À/À cultures were significantly larger than those from RARg À/À cells ( Table 1 ), suggesting that RARa can impact on tumor growth.
RAR disruption does not affect Ras-induced targets
Oncogenic Ras, together with the loss of RARg, was necessary for in vivo tumor formation in the model employed here. Activated Ras signals through multiple downstream effectors, such as extracellular signalregulated kinase (ERK), c-Jun amino-terminal kinase (JNK), p38 kinase and Akt, each of which can contribute to cellular transformation (White et al., 1995; Khosravi-Far et al., 1996; Webb et al., 1998) . Certain of these targets have also been reported to be affected by RA in some cell types (Lee et al., 1999; Yen et al., 1999; Bost et al., 2002; Gianni et al., 2002) . It was therefore conceivable that loss of RARg might affect tumor formation through altered expression or activation of these kinases. To investigate such a possibility, we examined the effect of RAR ablation on activation of these intermediaries by various stimuli.
v-Ha-ras infection, serum or EGF all enhanced phosphorylation of ERK, JNK, p38 and Akt comparably in both wild-type and RARag À/À cells (Figure 1 ; compare lanes 2-6 with lane 1 and lanes 9-13 with lane 8). Insulin treatment likewise induced activation of Akt (Figure 1 ; compare lane 7 with lane 14). As these kinases represent the major mediators of Ras-induced tumorigenesis (White et al., 1995; Khosravi-Far et al., 1996; Webb et al., 1998; Sebolt-Leopold, 2000) , it would appear unlikely that RAR loss impacted on tumor formation by altering the activity of these intermediaries.
Ablation of RARg attenuates RA-induced cell cycle arrest and apoptosis
Cellular transformation typically affects multiple cellular characteristics, including resistance to growth inhibitory and apoptogenic stimuli (Hanahan and Weinberg, 2000) . RA can cause cell-cycle arrest and apoptosis of many transformed cell types, and loss of RARs may affect these outcomes. We therefore tested the effect of RAR ablation on cell cycle arrest and/or apoptosis in the transformed keratinocyte lines.
When cultured in complete media, RA does not cause significant cell death, although RARg-dependent growth inhibition is observed (Goyette et al., 2000) . However, omission of EGF, insulin, hydrocortisone and cholera toxin from the complete media resulted in potent RAinduced cell-cycle arrest and apoptosis. Synchronized wild-type and RARa-null cultures treated with RA for 48 h exhibited an accumulation of cells in G0/G1 and a decrease in S þ G2/M populations ( Figure 2a) . In marked contrast, G1 arrest was not seen in RARg
or RARag À/À cultures, which exhibited cell-cycle profiles similar to vehicle-treated control cultures ( Figure 2a ). These observations suggest that loss of RARg, but not RARa, abolished the inhibitory effect of RA on cellcycle progression.
We assessed expression of several cell-cycle regulators involved in regulating the G1 to S-phase transition, including p21 cip1 , p27 kip1 , cyclin D1 and pRb, each of which has been shown to be affected by exogenous RA in diverse cell types (Boyle et al., 1999; Naderi and Blomhoff, 1999; Borriello et al., 2000) . Since no significant difference was seen between the wild-type and RARa À/À keratinocytes or between the RARg
and RARag À/À keratinocytes as regards cell-cycle arrest, we compared the effect of RA on the expression of these proteins between wild-type and RARag À/À keratinocytes.
Phosphorylation of Rb by cyclin-dependent kinases (CDKs) in late G1 provides a checkpoint control for G1 to S phase transition via release of E2F proteins (Classon and Harlow, 2002; Stevaux and Dyson, 2002) . In both wild-type and RARag-null cultures, only the hyperphosphorylated form of Rb (ppRb) is seen 48 h after the addition of serum to starved cells ( Figure 2b ; lanes 1 and 3). RA treatment inhibited Rb hyperphosphorylation in the wild-type cultures, but did not affect Rb expression, irrespective of receptor status ( Figure 2b ; lanes 2 and 4). RA treatment also caused an RARdependent increase in the expression of both p21 cip1 and p27 kip1 , both of which are negative regulators of G1 CDKs, and a decrease in the level of cyclin D1, a positive regulator of G1 CDKs (Weinberg, 1995; Mittnacht, 1998) ( cip1 by Western blot as described in Materials and methods. * Hypophosphorylated pRb; ** hyperphosphorylated pRb Figure 1 Western blot analysis of the effect of RAR disruption on Ras targets. Wild-type or RARag À/À cultures were either transduced with v-Ha-ras at an MOI of 1 or were treated with the noted stimuli. Whole-cell extracts were prepared at the times noted above each lane and subjected to Western blot analysis as described in Materials and methods
In addition to cell-cycle arrest, RA can also induce apoptosis in many cell types. Consistent with this, RA induced morphological features of apoptosis, such as membrane blebbing, in both wild-type and RARa À/À cultures. Such effects were, however, not observed in the RA-treated RARg À/À or RARag À/À cultures (data not shown). These observations were consistent with annexin V binding ( Figure 3a) and Hoechst staining assays (data not shown), both of which suggest that RA induces apoptosis in wild-type and RARa cultures, but not in RARg À/À or RARag À/À cells. Consist with these data, RA treatment of wild-type and RARa À/À cultures, but not RARg À/À or RARag À/À lines, was associated with processing of procaspase-3 to its active form (Figure 3b ). To ensure that this block was not an inherent feature of the resistant RAR-null lines, we assessed caspase-3 activation following treatment with 4-HPR (4-hydroxyphenretinamide), a synthetic retinoid that can induce growth arrest and apoptosis in an RAR-independent manner (Goyette et al., 2000; Wu et al., 2001) . In contrast to RA, 4-HPR induced apoptosis and activation of caspase-3 in both wild-type and RARag À/À cultures ( Figure 3b ). This observation suggests that the lack of induction of apoptosis in RARag-null cells is directly attributable to receptor loss, and is not a defect inherent to this particular line.
RAR reconstitution restores RA responsiveness and reverses the tumorigenic potential of Ras-transduced RARag À/À keratinocytes Decreased expression of RAR is seen in many cancer cell lines (Sun and Lotan, 2002) , and restoration of RAR expression can suppress tumorigenesis of some such lines in vivo (Houle et al., 1993) . Consistent with these data, we have found that multiple, independent, , were recovered which exhibited receptor levels slightly greater than total RAR protein values found in wild-type cells, as judged by electrophoretic mobility shift assay (EMSA) (Figure 4a ; lanes 9 and 10). Each of these reconstituted cell lines also mediated induction of an RARE reporter that was greater than that seen in wild-type keratinocytes (Figure 4b ). Two typical lines reconstituted with RARg displayed much lower levels of expression by EMSA (Figure 4a ; lanes 11 and 12), and exhibited an induction of the RARE reporter greater than RAR null cells, but less than that seen in wild-type cultures (Figure 4b ). In this regard, while a number of clones expressing considerable levels of RARa were recovered, we were unable to derive clones expressing more than trace amounts of RARg. It is notable that a similar phenomenon has been seen in some cancer cell lines that are incapable of re-expression of certain tumor suppressors (Weinstein, 2002) .
Exogenous RA mediates significant growth inhibition of wild-type cells, while RARag À/À cultures are completely resistant to this effect (Figure 4c ). In clones reexpressing RARa, growth inhibition was partially (IRES-RARa Trans-repression of AP-1 activity is one mechanism that has been proposed to underlie the growth inhibitory effects of retinoids (Altucci and Gronemeyer, 2001; Fontana and Rishi, 2002) . Consistent with this, RA repressed the activity of an AP-1 reporter in wild-type, but not in RAR-null, keratinocytes (Figure 4d ). Transrepression in RARag À/À cells was recovered in lines reexpressing high levels of RARa (Figure 4d ), in good agreement with the growth inhibitory effects of RA in these clones (Figure 4c) . Notably, however, transrepression did not strictly correlate with either relative receptor levels (Figure 4a ) or activation of an RARE (Figure 4b ). RA also failed to repress AP-1 activity in lines expressing low levels of RARa or RARg (Figure 4d and data not shown).
To determine whether re-expression of RARs could repress the tumorigenic potential of RAR-null keratinocytes, we compared tumor formation between parental RARag À/À cells and receptor-reconstituted clones. In marked contrast to RARag À/À cells, which formed solid tumors at a high incidence, neither of the clones overexpressing RARa yielded tumors (Table 2) . However, tumors were derived from clones expressing low levels of either RARa or RARg levels at an incidence (Table 2 and data not shown).
Discussion
Gene silencing of RARb is associated with many types of solid tumors such as head and neck SCC, non-smallcell lung cancers, breast, prostatic and cervical cancers (Sun and Lotan, 2002) . Moreover, re-expression of RARb in cell lines exhibiting low levels of the receptor can decrease the tumorigenic phenotype. In addition, transgenic mice expressing antisense RARb2 spontaneously develop lung cancers (Houle et al., 1993; Berard et al., 1996) . These observations suggest that RARb may act as a tumor suppressor in a broad range of epithelial À/À or RAR re-expressing lines were transfected with a 3 Â TRE reporter plasmid. Luciferase activity was assessed 48 h after treatment with either vehicle or RA (1 mM). Values are the mean7standard deviation of three determinations, and are expressed as the percent activity of vehicle-treated cultures tissues (Sun and Lotan, 2002) . However, such an RARb-dependent function cannot impact on the epidermis, since this tissue does not express this particular RAR type (Darwiche et al., 1995; Fisher and Voorhees, 1996) .
Skin carcinogenesis is a multistage process, which includes tumor initiation, promotion and progression (Kinzler and Vogelstein, 1996; Yuspa et al., 1996) . Dietary retinoid intake has been associated with a reduction in the incidence of a number of cancers, although recent clinical trials have raised some questions as to the validity of this relationship in at least some cases (Altucci and Gronemeyer, 2001; Sun and Lotan, 2002) . In animal models, RA can inhibit papilloma formation and malignant conversion in chemical carcinogenesis protocols (Chen et al., 1995; De Luca et al., 1996) . These observations imply that RARs may play key roles in skin carcinogenesis. Indeed, expression of RARa and RARg have been found to be progressively lost with the advancement of skin carcinogenesis both in man and mouse (Darwiche et al., 1995; Xu et al., 2001) . In this regard, a role for PKC in suppression of RARs has been described in epidermal keratinocytes expressing oncogenic Ras (Darwiche et al., 1996) . Moreover, UV radiation, the major causative factor for human SCC (Marks, 1995) has been shown to reduce RARg expression in human epidermis through a post-transcriptional mechanism (Wang et al., 1999; Boudjelal et al., 2000) . These data are consistent with relationship between RAR loss and epidermal carcinogenesis, and suggest that several epigenetic mechanisms may contribute to this outcome in both man and mouse.
RARg functions as a tumor suppressor
To further investigate the relationship between RAR expression and epidermal carcinogenesis, we assessed the tumorigenic potential of a comprehensive panel of RAR-deficient keratinocyte lines. Loss of any RAR(s) by itself did not result in a tumorigenic phenotype. However, loss of RARg, but not RARa, predisposed keratinocytes to Ras-induced tumors in vivo, consistent with a role for RARg as a tumor suppressor in this cell type.
Tumors derived from both RARg À/À and RARag
cultures exhibited histological properties consistent with SCC. Loss of expression of K10, a hallmark of malignant conversion (Nelson and Slaga, 1982) , and gain of K8, a marker associated with late stage epidermal malignancy (Larcher et al., 1992) , are consistent with this conclusion. The finding also suggests that RARg might affect tumor progression and/or malignant conversion. Although others have proposed that loss of RARa plays a critical role in epidermal tumorigenesis (Darwiche et al., 1996; Hansen et al., 2003) , loss of RARa alone did not affect the incidence of tumor formation in this study. However, RARag À/À tumors were significantly larger than those derived from RARg À/À cultures, suggesting that RARa impacts on events related to tumor growth. Moreover, reintroduction of RARa in RAR-null keratinocytes reverted the tumorigenic phenotype. As RARg is the most prevalent RAR type expressed in keratinocytes (Darwiche et al., 1995; Fisher and Voorhees, 1996; Goyette et al., 2000) , the most simplistic interpretation of these observations is that both receptor types functionally overlap, and that ablation of endogenous RARg, but not RARa, results in the loss of a critical threshold of receptor activity and subsequent sensitivity to Ras-induced tumor formation. Similar functional overlap has also been described for RAR-null mice Ghyselinck et al., 1997; Mendelsohn et al., 1994) , although such apparent redundancy may be an artifactual manifestation of gene disruption (Taneja et al., , 1996 .
Loss of RARs affects retinoid-induced cell cycle arrest, apoptosis and AP-1 activity
Ras signals through multiple downstream targets (Katz and McCormick, 1997; Rommel and Hafen, 1998) , many of which are involved in Ras-induced oncogenesis (White et al., 1995; Khosravi-Far et al., 1996; Webb et al., 1998) . RA has been shown to affect the expression or activation of certain of these intermediaries (Lee et al., 1999; Yen et al., 1999; Bost et al., 2002; Gianni et al., 2002) , raising the possibility that loss of RARs might impact on tumorigenesis through altered expression or function of these Ras targets. However, Western blot analysis revealed no appreciable differences between wild-type and RARag À/À cells in terms of the expression or activation of any of these intermediaries.
Cancer cells acquire properties, including the ability to resist growth inhibitory and apoptogenic stimuli, which confer a selective growth advantage (Hanahan and Weinberg, 2000) . We found that RA induced both cell-cycle arrest and apoptosis, and that these effects were mediated primarily through RARg. At the molecular level, cell-cycle arrest correlated with an upregulation of p21 cip1 and p27 kip1 , and loss of expression of cyclin D1; hypophosphorylation of pRb and arrest at G1 was likely secondary to these events. Apoptosis correlated with the activation of caspase-3, a classic death effector (Hengartner, 2000) . The lack of these outcomes in RAR-null keratinocytes was not due to an inherent defect, as reintroduction of RARa or administration of 4-HPR restored these responses. 
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Independent wild-type, RARag À/À or RARag À/À lines re-expressing RARa or RARg (IRES-RARa or RARg as indicated) were transduced with a v-Ha-ras retrovirus and tumor incidence in nude mice assessed as described in Materials and methods
Roles of RARc in epithelial tumorigenesis CF Chen et al
While the principle retinoid target(s) mediating growth arrest is presently unknown, expression of p21 cip1 , p27 kip1 and cyclin D1 is affected in a similar manner by RA in a number of systems. For example, p21 cip1 has been shown to be directly regulated by RARs, and this induction correlates with growth arrest (Liu et al., 1996) . Retinoids have been shown to impact on the expression of p27 kip1 and cyclin D1 in a posttranslational manner, again correlating with growth inhibition (Langenfeld et al., 1997; Dimberg et al., 2002) . Retinoid-induced cell-cycle arrest has also been associated with reduced Rb hyperphosphorylation, and it has been proposed that this outcome is secondary to downregulation of cyclins and induction of CDK inhibitors, including p21 cip1 and/or p27 kip1 (Naderi and Blomhoff, 1999; Zhang et al., 2001) . Retinoids have also been shown to initiate apoptotic programs, including activation of caspase-3, in a number of cell types (Pepper et al., 2002) .
In the present study, p21 cip1 , p27 kip1 and cyclin D1 were all affected by RA in a manner that correlated closely with growth inhibition and apoptosis, and inversely with the tumorigenic potential of wild-type and RAR-null lines. It is therefore conceivable that misregulation of one or more of these targets underlies the predisposition of RAR-null keratinocytes to Rasinduced tumorigenesis. In agreement with this, cyclin D1 has been shown to play a key role in Ras-induced epidermal tumors (Robles et al., 1998) , while Rb is frequently mutated in a number of epithelial cancers (Nevins 2001; Classon and Harlow, 2002) . Attenuation of p21 cip1 to Ras signaling has been associated with Rasinduced hyperplasia (Philipp et al., 1999; Topley et al., 1999; Adnane et al., 2000) , while reduced p27 kip expression has been correlated with a number of cancers (Moller, 2000) .
Although retinoids have been shown to impact on the expression of a number of cyclins and CDK inhibitors, the role of the various RARs on growth inhibition and expression of these cell-cycle effectors appears to differ depending on the cell type examined. For instance, RARa has been demonstrated to be important in mediating growth arrest in several breast carcinoma cell lines, and in retinoid-induced apoptosis in a rat tracheobronchial epithelial cell line (Sheikh et al., 1994; Zhang et al., 1995) . In contrast, in F9 embryocarcinoma cells, loss of RARb (but not RARa or RARg) leads to resistance to retinoid-mediated growth inhibition (Faria et al., 1999) . Extinction of RARb has also been suggested to play a key role in head and neck, breast, ovarian and lung cancers (Sun and Lotan, 2002) . However, RARb is not expressed in epidermal keratinocytes, and our prior work suggests that RARg plays a pivotal role in retinoid-induced growth arrest in this cell type (Goyette et al., 2000) . RARg has also been shown to mediate RA response of cell lines derived from head and neck SCCs and oral SCCs, where RARb expression has been silenced (Oridate et al., 1996; Le et al., 2000; Klaassen et al., 2001) .
Retinoids can trans-regulate a number of signaling pathways, such as AP-1, in diverse cell types (Altucci and Gronemeyer, 2001; Mehta, 2003) , and AP-1, signaling is inhibited by RA in wild-type, but not RAR-null, keratinocytes. This effect is recovered in the latter after the reintroduction of RARa, and correlates with resistance to Ras-induced tumorigenesis. In this regard, a number of studies suggest a key role for AP-1 signaling in epidermal tumorigenesis (Huang et al., 1997; Jochum et al., 2001; Young et al., 1999) . Moreover, as AP-1 signaling has been linked to the regulation of both cell cycle and apoptosis (Shaulian and Karin, 2002) , it is tempting to speculate that repression of this pathway may be a pivotal means by which retinoids mediate their tumor suppression effects.
Receptor specificity or redundancy?
In an attempt to determine whether reconstitution of RAR expression in RAR-null keratinocytes could suppress Ras-induced tumorigenesis, we derived a number of cell lines re-expressing RARa or RARg. It is notable that, although some lines expressing high levels of RARa were obtained, we were unable to recover clones expressing significant levels of RARg. Similar observations have been made as regards stable expression of RARb in certain cell types (WEC Bradley, personal communication) . This phenomenon resembles the effect of tumor suppressor gene hypersensitivity, which has been described for some cancer cell lines, whereby reintroduction of a tumor suppressor gene, which has been silenced or functionally mutated in the host line is difficult to effect due to cell death or growth inhibition mediated by the introduction of the exogenous gene (Weinstein, 2002) . The fact that RARa, but not RARg, clones expressing appreciable levels of functional receptor were recovered may be indicative of some events related to growth inhibition or apoptosis which are mediated preferentially by high levels of RARg. However, as the tumorigenic phenotype was suppressed by RARa, any such putative RARg function would not be essential for RAR-dependent tumor suppression in vivo.
Although RARa can suppress Ras-induced tumor formation, several other observations suggest that it functionally differs from RARg. For example, both RARa-and RARg-null cell lines exhibit essentially equivalent transcriptional potency in inducing an RARE reporter, although the latter receptor type represents approximately 90% of all RAR protein in wild-type keratinocytes. Conversely, endogenous RARg is the major mediator of retinoid-induced growth arrest, tumor suppression and trans-repression of AP-1 activity (Goyette et al., 2000) . These observations are consistent with prior work suggesting that, while the RARs exhibit functional overlap, they may differ in their relative efficacy as regards certain parameters Taneja et al., 1995; Chiba et al., 1997a, b) . Thus, while exogenous RARa can compensate for the loss of RARg in suppressing tumor formation, it also suggests that RARE induction is an irrelevant predictor of this outcome, while trans-suppression of AP-1 and growth inhibition appear to be more relevant parameters.
In conclusion, our data demonstrate that endogenous RARg functions in a manner consistent with it being a tumor suppressor in the context of this model system. Whether RARg functions in a similar manner in other systems is presently under investigation. Moreover, while repression of AP-1 activity correlates well with RAR-mediated inhibition of tumorigenesis, the target genes mediating this effect are presently undefined.
Materials and methods
Cell culture
Wild-type, RARa À/À , RARg À/À and RARag À/À keratinocyte lines were established from the epidermis of the corresponding mouse mutant fetus at term (embryonic day 18.5), as described in detail elsewhere (Goyette et al., 2000) . Unless otherwise noted, cells were maintained in complete media comprised of S-minimal essential medium (S-MEM, Invitrogen), supplemented with L-glutamine (2 mM), sodium pyruvate (1 mM, Invitrogen), 10% chelex (Bio-Rad)-treated fetal calf serum (Invitrogen), epidermal growth factor (10 ng/ml), insulin (5 mg/ml), hydrocortisone (0.5 mM), cholera toxin (1.2 Â 10 À11 M), adenine sulfate (24 mg/ml), and gentamicin (10 mg/ml; all from Sigma) and MgCl 2 (1.5 mM) at a final calcium concentration of 0.05 mM as described previously (Goyette et al., 2000) .
Growth assay
Cells were seeded on 96-well tissue culture plates (Nunc) at a density of 800 cells/well. At 24 h postplating, media was changed to include either vehicle dimethyl sulfoxide; (0.1%, v/ v) or RA (1 mM) with daily replenishment for 10-14 days. DNA content was assessed using crystal violet staining (Kueng et al., 1989) , with dye binding measured using a microplate reader (Molecular Devices) at 595 nm. Growth was expressed as the mean absorbance value at 595 nm (A 595 ) of four independent determinations.
Cell-cycle analysis
Cells were seeded on 100 mm tissue culture dishes (Nunc). After 24 h in complete media, cells were synchronized by culture in media 0.1% in serum for 30 h, and subsequently treated with RA (5 mM) or vehicle in media 10% in serum for 48 h. Cells were then harvested, fixed in 75% ethanol at À201C overnight and stained with propidium iodide (PI, Sigma) in the presence of RNAase A. Cell-cycle populations were assessed by FACScan analysis (Becton Dickinson).
Apoptosis analysis
Cells were seeded on 100 mm tissue culture dishes. After 24 h of culture in complete media, cells were washed twice with phosphate-buffered saline (PBS) and treated with RA (5 mM, Sigma) or vehicle in S-MEM containing 10% serum. Cells were harvested 48 h post-treatment and apoptosis assessed by annexin V (BD Biosciences) binding.
RARE and AP-1 reporter assays
Cells were seeded in six-well tissue culture dishes (Becton Dickinson). After 24 h of culture in complete media, cells were transiently transfected using Lipofect ACE (Invitrogen) with luciferase reporter plasmids (1 mg/well) harboring either a 3 Â bRARE or a 3 Â TPA-reponsive element (TRE) as described previously (Goyette et al., 2000; Angel and Karin, 1992) . A lacZ expression vector was included in all assays to control for transfection efficiency. Following transfection, cells were treated with RA (1 mM) or vehicle and luciferase activity assessed 24-48 h post-treatment as described previously (Goyette et al., 2000) . Reporter activity was expressed as the mean7the standard deviation of independent triplicate transfections.
Western blot analysis
Cells were cultured in 100 mm plates in the presence of 10 À6 M RA or vehicle alone. Protein concentration from whole-cell lysates were determined using the DC protein assay kit (BioRad). In all, 40 mg of protein were solubilized in loading buffer, fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and electroblotted to an immobilon-P PVDF membrane as recommended by the supplier (Millipore). Proteins of interest were detected using the appropriate antibodies with ECL (Amersham).
For kinase activation assays, cells were starved for 30 h in S-MEM lacking serum, EGF and insulin, and subsequently stimulated with serum (10%), EGF (10 ng/ml), or insulin (5 mg/ ml) for 5-20 min prior to lysis. Phosphoproteins were revealed using monoclonal antibodies against phospho-ERK1/2 (New England), phospho-JNK (Santa Cruz), or phospho-p38 MAP kinase (CalBiochem), or a polyclonal antibody against phospho-Akt (Cell signaling).
For cell-cycle analysis, primary antibodies against p21 cip1 , p27 kip1 , cyclinD1, pRb (from Santa Cruz) and phosphorylated Rb (Pharmingen) were employed. Caspase-3 cleavage was detected using an antibody against the active form of the enzyme (Cell Signaling).
Reconstitution of RAR expression
RARag double-null keratinocytes were electroporated with linearized expression vectors encoding either RARa1 or RARg1 in pIRESpuro (Clontech), and puromicin-resistant clones isolated by limiting dilution. RAR function and expression in clonal isolates was assessed by RARE reporter assay and by EMSA, respectively.
Electrophoretic mobility shift assay EMSA was performed as described previously (Houle et al., 2000; Goyette et al., 2000) . Briefly, nuclear protein extracts (3 mg) in 13.4 mM HEPES (pH 7.5), 30 mM KCl, 1mM dithiothreitiol, 3% glycerol, 0.1% NP-40, 0.25 mg/ml BSA and 60 ng/ml poly(dI-dC) were incubated for 30 min on ice, following which a 32 P-labeled oligonucleotide probe encoding an RARE was added and incubation continued at room temperature for an additional 30 min. Protein-DNA complexes were resolved by PAGE and revealed by autoradiography.
Retroviral infection and tumorigenicity assay
At 2 days after plating, keratinocytes were infected with a vHa-ras retrovirus at an MOI of 1-2 as described previously (Roop et al., 1986) . Cultures were harvested 4 days after infection and resuspended in PBS at a density of 10 7 cells/ml. A total of 1 Â 10 6 cells were injected s.c. into athymic nude mice and tumor incidence and size noted 6-8 weeks postinjection. Tumors were subsequently processed for Northern or Southern blot analysis or were fixed in Bouin's solution (Sigma) and embedded in paraffin for histopathological evaluation.
Abbreviations AP-1, activating protein 1; DMSO, dimethyl sulfoxide; ERK, extracellular signal-regulated kinase; JNK, c-Jun aminoterminal kinase; RA, all-trans retinoic acid; RAR, retinoic acid receptor; RARE, retinoic acid-responsive element; RXR, retinoid X receptor; SCC, squamous cell carcinoma; s.c., subcutaneous; TPA, 12-O-tetradecanolphorbol-13-acetate; TRE, TPA-responsive element.
